Medicare Enrolled

Dr. Marvin Baula, M.D.

Psychiatry · Middletown, OH
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4464 S DIXIE HWY, Middletown, OH 45005
5136498008
In practice since 2009 (16 years)
NPI: 1104156819 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Baula from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Baula? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Baula

Dr. Marvin Baula is a psychiatry specialist in Middletown, OH, with 16 years of NPI registration. Based on federal Medicare data, Dr. Baula performed 276 Medicare services across 73 unique beneficiaries.

Between the years covered by Open Payments, Dr. Baula received a total of $14,239 from 30 pharmaceutical and/or device companies across 995 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Baula is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice ▲ Top 36% volume in OH $14,239 industry payments

Medicare Practice Summary

Medicare Utilization ↗
276
Medicare services
Top 36% in OH for psychiatry
73
Unique beneficiaries
$87
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~17 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
262 $89 $128
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
14 $54 $198
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$14,239
Total received (2018-2024)
Avg $2,373/year across 6 years
Top 7% in OH for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
30
Companies
995
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,624 (95.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$615 (4.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,381
2023
$3,558
2022
$2,993
2021
$116
2019
$698
2018
$2,493

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Axsome Therapeutics, Inc.
$581
Teva Pharmaceuticals USA, Inc.
$513
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$480
Janssen Pharmaceuticals, Inc
$458
ABBVIE INC.
$370
Lundbeck LLC
$332
Vanda Pharmaceuticals Inc.
$317
Alkermes, Inc.
$227
Otsuka America Pharmaceutical, Inc.
$223
Almatica Pharma LLC
$203
Neurocrine Biosciences, Inc.
$183
Tris Pharma Inc
$181
Supernus Pharmaceuticals, Inc.
$124
Corium, LLC
$85
Takeda Pharmaceuticals U.S.A., Inc.
$46
Sage Therapeutics, Inc.
$22
Otsuka Pharmaceutical Development & Commercialization, Inc.
$20
E.R. Squibb & Sons, L.L.C.
$18
Top 3 companies account for 35.9% of 2024 payments
All-time payments by company (2018-2024) ›
Janssen Pharmaceuticals, Inc
$1,887
Otsuka America Pharmaceutical, Inc.
$1,263
Alkermes, Inc.
$1,238
Axsome Therapeutics, Inc.
$1,133
Teva Pharmaceuticals USA, Inc.
$1,059
Lundbeck LLC
$1,033
Sunovion Pharmaceuticals Inc.
$989
Supernus Pharmaceuticals, Inc.
$838
Vanda Pharmaceuticals Inc.
$791
ABBVIE INC.
$570
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$480
AbbVie Inc.
$440
ITI, Inc.
$436
Takeda Pharmaceuticals U.S.A., Inc.
$357
Allergan Inc.
$356
Neurocrine Biosciences, Inc.
$337
Almatica Pharma LLC
$301
Corium, LLC
$189
Tris Pharma Inc
$181
Otsuka Pharmaceutical Development & Commercialization, Inc.
$92
Shire North American Group Inc
$62
Avanir Pharmaceuticals, Inc.
$42
Ironshore Pharmaceuticals Inc.
$35
Indivior Inc.
$28
Merck Sharp & Dohme Corporation
$23
Sage Therapeutics, Inc.
$22
E.R. Squibb & Sons, L.L.C.
$18
US WorldMeds, LLC
$14
Merck Sharp & Dohme LLC
$14
ARBOR PHARMACEUTICALS, INC.
$11
Top 3 companies account for 30.8% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ARISTADA · AUSTEDO · AZSTARYS · Aristada 441 mg · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · CAPLYTA · Dyanavel XR · FANAPT · Fanapt · GRALISE · HETLIOZ · Hetlioz · Horizant · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · LATUDA · LOREEV XR · LYBALVI · Lucemyra/Lofexidine · MYDAYIS · NUEDEXTA · Nuedexta · QELBREE · Qelbree · REXULTI · SPRAVATO · SUBLOCADE · Sunosi · TRINTELLIX · Trintellix · UZEDY · VIIBRYD · VIVITROL · VRAYLAR · VYVANSE · Vivitrol · Vivitrol 380 mg · ZURZUVAE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for psychiatry in OH.

Looking for a psychiatry specialist in Middletown?
Compare psychiatrists in the Middletown area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
197
Per 100K population
80.0
County median income
$107,843
Nearest hospital
ATRIUM MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Baula is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 7% of OH peers, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Baula experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Baula performed 262 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Baula receive payments from pharmaceutical companies?
Yes. Dr. Baula received a total of $14,239 from 30 companies across 995 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Baula's costs compare to other psychiatrists in Middletown?
Dr. Baula's average Medicare payment per service is $87. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Baula) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →